Evidence map›Paper›PMID 39349242›Full record

ArticleEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists2025

The University of Iowa Neuroendocrine Tumor Clinic.

James R Howe, Yusuf Menda, Chandrikha Chandrasekharan, Andrew M Bellizzi, Dawn E Quelle, M Sue O'Dorisio, Joseph S Dillon

Abstract readHistorical Article
In one paragraph

Article in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James R HoweDepartment of Surgery, University of Iowa Carver College of Medicine, Iowa City, Iowa. Electronic address: james-howe@uiowa.edu.
Yusuf MendaDepartment of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Chandrikha ChandrasekharanDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Andrew M BellizziDepartment of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Dawn E QuelleDepartments of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, Iowa.
M Sue O'DorisioDepartment of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Joseph S DillonDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.

Funding

Project 4: New Approaches to Improving the Effectiveness of Radionuclide Targeted Treatments in Neuroendocrine TumorsP50CA174521 · NCI · UNIVERSITY OF IOWA · PI ODORISIO, THOMAS · 2015 to 2021
$13.2M
Role of RABL6A-PP2A in neuroendocrine tumorsR01CA260200 · NCI · UNIVERSITY OF IOWA · PI NARLA, GOUTHAM, QUELLE, DAWN E · 2021 to 2025
$2.6M
NCI NIH HHS P50 CA174521NCI NIH HHS R01 CA260200
6 · The paper itself

Abstract

The Iowa Neuroendocrine Tumor (NET) Clinic was founded and developed by two remarkable physicians, Thomas and Sue O'Dorisio. Tom was an Endocrinologist and close friend and colleague of Aaron Vinik. Both men were pioneers in studies of gastrointestinal hormones and the management of patients with NETs. Sue was a Pediatric Oncologist and research scientist with great expertise in new drug development and clinical trials. She and Tom were leaders in bringing somatostatin analogs and somatostatin-conjugated radioligands to the clinic for the therapy and diagnosis of NETs. All three physicians received lifetime achievement awards for their contributions to the field of NETs. This is the story of how the Iowa NET Clinic developed over the years to become a model for the multidisciplinary mantagement of patients with NETs, culminating in its designation as a European Neuroendocrine Tumor Society NET Center of Excellence, and the receipt of a Specialized Project of Research Excellence (SPORE) grant for the study of NETs from the National Institutes of Health.

Indexed as

Neuroendocrine TumorsEndocrinologyHistory, 20th CenturyHistory, 21st CenturyHumansIowaneuroendocrinepancreassmall bowel

Identifiers

PMID39349242
PMCPMC11700786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.